Dysfunctional HDAC8 Impacts Genomic Integrity and Is a Novel Therapeutic Target in Multiple Myeloma
Year: 2021
Type: conference-abstract
Source: Blood
Institutions: Harvard University, University of Ostrava, University Hospital Ostrava, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, VA Boston Healthcare System, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Boston University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3211787825
